Altanserin

278-422-1

3-(2-(4-(4-Fluorobenzoyl)-1-piperidinyl)ethyl)-2,3-dihydro-2-thioxo-4(1H)-quinazolinone

3-{2-[4-(4-Fluorbenzoyl)-1-piperidinyl]ethyl}-2-thioxo-2,3-dihydro-4(1H)-chinazolinon

3-{2-[4-(4-Fluorobenzoyl)-1-piperidinyl]ethyl}-2-thioxo-2,3-dihydro-4(1H)-quinazolinone

3-{2-[4-(4-Fluorobenzoyl)-1-pipéridinyl]éthyl}-2-thioxo-2,3-dihydro-4(1H)-quinazolinone

3-{2-[4-(4-Fluorobenzoyl)piperidin-1-yl]ethyl}-2-thioxo-2,3-dihydroquinazolin-4(1H)-one

4(1H)-Quinazolinone, 3-[2-[4-(4-fluorobenzoyl)-1-piperidinyl]ethyl]-2,3-dihydro-2-thioxo-

5015H744JQ

76330-71-7

Altanserin

3-(2-(4-(4-Fluorbenzoyl)piperidino)ethyl)-1,2,3,4-tetrahydro-2-thioxo-4-chinazolinon

3-(2-(4-(4-fluorobenzoyl)piperidin-1-yl)ethyl)-2-thioxo-2,3-dihydroquinazolin-4(1H)-one

3-(2-(4-(p-Fluorobenzoyl)piperidino)ethyl)-2-thio-2,4(1H,3H)-quinazolinedione

3-[2-[4-(4-FLUOROBENZOYL)-1-PIPERIDINYL]ETHYL]-2,3-DIHYDRO-2-THIOXO-4(1H)-QUINAZOLINONEHYDROCHLORIDE

3-[2-[4-(4-fluorobenzoyl)-1-piperidyl]ethyl]-2-thioxo-1H-quinazolin-4-one

3-[2-[4-(4-fluorobenzoyl)piperidin-1-yl]ethyl]-2-sulfanylidene-1H-quinazolin-4-one

3-[2-[4-(4-fluorophenyl)carbonylpiperidin-1-yl]ethyl]-2-sulfanylidene-1H-quinazolin-4-one

3-[2-[4-[(4-fluorophenyl)-oxomethyl]-1-piperidinyl]ethyl]-2-thioxo-1H-quinazolin-4-one

3-{2-[4-(4-Fluoro-benzoyl)-piperidin-1-yl]-ethyl}-2-thioxo-2,3-dihydro-1H-quinazolin-4-one

4(1H)-Quinazolinone, 3-(2-(4-(4-fluorobenzoyl)-1-piperidinyl)ethyl)-2,3-dihydro-2-thioxo-

5-hydroxytryptamine receptor 2A

5HT2A_HUMAN

5HT2A_RAT

ADA1A_RAT

ADA2C_RAT

Altanserina

altanserina

Altanserine

altansérine

Altanserinum

altanserinum

D(2) dopamine receptor

DRD2_RAT

EINECS 278-422-1

MFCD00868052

MFCD11045280

PDSP1_001703

PDSP2_001686

α-1A adrenergic receptor

α-2C adrenergic receptor

алтансерин

ألتانسيرين

阿坦色林